Centre for Environmental Health Research, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Part Fibre Toxicol. 2010 Dec 2;7(1):37. doi: 10.1186/1743-8977-7-37.
Nanoparticle (NP) toxicity testing comes with many challenges. Characterization of the test substance is of crucial importance and in the case of NPs, agglomeration/aggregation state in physiological media needs to be considered. In this study, we have addressed the effect of agglomerated versus single particle suspensions of nano- and submicron sized gold on the inflammatory response in the lung. Rats were exposed to a single dose of 1.6 mg/kg body weight (bw) of spherical gold particles with geometric diameters of 50 nm or 250 nm diluted either by ultrapure water or by adding phosphate buffered saline (PBS). A single dose of 1.6 mg/kg bw DQ12 quartz was used as a positive control for pulmonary inflammation. Extensive characterization of the particle suspensions has been performed by determining the zetapotential, pH, gold concentration and particle size distribution. Primary particle size and particle purity has been verified using transmission electron microscopy (TEM) techniques. Pulmonary inflammation (total cell number, differential cell count and pro-inflammatory cytokines), cell damage (total protein and albumin) and cytotoxicity (alkaline phosphatase and lactate dehydrogenase) were determined in bronchoalveolar lavage fluid (BALF) and acute systemic effects in blood (total cell number, differential cell counts, fibrinogen and C-reactive protein) 3 and 24 hours post exposure. Uptake of gold particles in alveolar macrophages has been determined by TEM.
Particles diluted in ultrapure water are well dispersed, while agglomerates are formed when diluting in PBS. The particle size of the 50 nm particles was confirmed, while the 250 nm particles appear to be 200 nm using tracking analysis and 210 nm using TEM. No major differences in pulmonary and systemic toxicity markers were observed after instillation of agglomerated versus single gold particles of different sizes. Both agglomerated as well as single nanoparticles were taken up by macrophages.
Primary particle size, gold concentration and particle purity are important features to check, since these characteristics may deviate from the manufacturer's description. Suspensions of well dispersed 50 nm and 250 nm particles as well as their agglomerates produced very mild pulmonary inflammation at the same mass based dose. We conclude that single 50 nm gold particles do not pose a greater acute hazard than their agglomerates or slightly larger gold particles when using pulmonary inflammation as a marker for toxicity.
纳米颗粒(NP)毒性测试存在诸多挑战。测试物质的特性至关重要,在 NP 的情况下,需要考虑其在生理介质中的团聚/聚集状态。在这项研究中,我们研究了团聚态和单分散态纳米和亚微米尺寸金颗粒对肺部炎症反应的影响。大鼠经口暴露于 1.6mg/kg 体重(BW)的 50nm 或 250nm 球形金颗粒,颗粒分别分散于超纯水或添加磷酸盐缓冲盐水(PBS)中。1.6mg/kg BW 的 DQ12 石英被用作肺部炎症的阳性对照。通过测定 Zeta 电位、pH 值、金浓度和颗粒粒径分布对颗粒悬浮液进行了广泛的特性描述。使用透射电子显微镜(TEM)技术对原始颗粒尺寸和颗粒纯度进行了验证。通过支气管肺泡灌洗液(BALF)测定了肺部炎症(总细胞数、分类细胞计数和促炎细胞因子)、细胞损伤(总蛋白和白蛋白)和细胞毒性(碱性磷酸酶和乳酸脱氢酶),并在暴露后 3 和 24 小时测定了血液中的急性全身效应(总细胞数、分类细胞计数、纤维蛋白原和 C 反应蛋白)。通过 TEM 测定了肺泡巨噬细胞中摄取的金颗粒。
在超纯水中稀释的颗粒分散良好,而在 PBS 中稀释时则形成团聚体。确认了 50nm 颗粒的粒径,而使用追踪分析和 TEM 则表明 250nm 颗粒的粒径为 210nm。注入不同大小的团聚态和单分散态金颗粒后,肺部和全身毒性标志物未见明显差异。巨噬细胞摄取了团聚态和单分散态纳米颗粒。
原始颗粒尺寸、金浓度和颗粒纯度是重要的检查特征,因为这些特性可能与制造商的描述不符。在相同质量剂量下,分散良好的 50nm 和 250nm 颗粒及其团聚体产生了非常轻微的肺部炎症。我们得出结论,在使用肺部炎症作为毒性标志物时,单分散态 50nm 金颗粒的急性危害并不大于其团聚体或稍大的金颗粒。